Lyle J Arnold, Biocept's SR VP of R&D and CSO, recently acquired 45,000 shares of the company. The buys took place at $1.10 per share, on October 19, 2016. Arnold now owns 65,238 shares of the company. Arnold operates out of San Diego, CA. Some additional info was provided as follows:
Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 40,476 fewer shares.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!